362 related articles for article (PubMed ID: 37365028)
1. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
2. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
Wu T; Li N; Luo F; Chen Z; Ma L; Hu T; Hong G; Li H
BMC Bioinformatics; 2023 Apr; 24(1):176. PubMed ID: 37120506
[TBL] [Abstract][Full Text] [Related]
3. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic model based on immunogenic cell death-related genes for improved risk stratification in hepatocellular carcinoma patients.
Liu T; Chen X; Peng B; Liang C; Zhang H; Wang S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10255-10267. PubMed ID: 37269346
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma.
Yang WX; Gao HW; Cui JB; Zhang AA; Wang FF; Xie JQ; Lu MH; You CG
BMC Bioinformatics; 2023 Mar; 24(1):89. PubMed ID: 36894886
[TBL] [Abstract][Full Text] [Related]
7. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis.
Wang H; Wang N; Tang Z; Liu Q; Nie S; Tao W
Hereditas; 2023 Jul; 160(1):30. PubMed ID: 37464443
[TBL] [Abstract][Full Text] [Related]
8. Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma.
Nie G; Zhu X; Zhang H; Wang H; Yan J; Li X
Cancer Rep (Hoboken); 2024 Apr; 7(4):e1978. PubMed ID: 38599581
[TBL] [Abstract][Full Text] [Related]
9. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
Wang S; Bai H; Fei S; Miao B
Biochem Genet; 2023 Oct; ():. PubMed ID: 37898914
[TBL] [Abstract][Full Text] [Related]
10. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
[TBL] [Abstract][Full Text] [Related]
11. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
13. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
[TBL] [Abstract][Full Text] [Related]
14. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
16. Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma.
Sun L; Wu Z; Dong C; Yu S; Huang H; Chen Z; Wu Z; Yin X
BMC Med Genomics; 2023 Jun; 16(1):130. PubMed ID: 37316840
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
18. A nomogram based on a three pyroptosis gene model and clinical parameters for predicting prognosis of hepatocellular carcinoma.
Zhou T; Wang T; Zeng K; Qin R; Jin Y; Chen P; Ju G
Gene; 2022 Apr; 819():146243. PubMed ID: 35122925
[TBL] [Abstract][Full Text] [Related]
19. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
